Mice with an induced mutation in collagen 8A2 develop larger eyes and are resistant to retinal ganglion cell damage in an experimental glaucoma model by Steinhart, Matthew R. et al.
Mice with an induced mutation in collagen 8A2 develop larger eyes
and are resistant to retinal ganglion cell damage in an experimental
glaucoma model
Matthew R. Steinhart,1 Frances E. Cone,1 Cathy Nguyen,1 Thao D. Nguyen,2 Mary E. Pease,1 Oliver Puk,3
Jochen Graw,3 Ericka N. Oglesby,1 Harry A. Quigley1
(The first two investigators contributed equally to this work)
1Glaucoma Center of Excellence, Wilmer Ophthalmological Institute, Johns Hopkins University, Baltimore, MD; 2Department of
Mechanical Engineering, Johns Hopkins University, Baltimore, MD; 3Institute of Developmental Genetics, Helmholtz Center,
Munich, Germany
Purpose: To study susceptibility to glaucoma injury as it may be affected by mutations in ocular connective tissue
components.
Methods: Mice homozygous for an N-ethyl-N-nitrosourea induced G257D exchange (Gly to Asp) missense mutation
(Aca23) in their collagen 8A2 gene were studied to measure intraocular pressure (IOP), axial length and width, number
of retinal ganglion cells (RGC), and inflation responses. Three month old homozygous Aca23 mutant and wild type (WT)
mice had 6 weeks exposure to elevated IOP induced by polystyrene microbead injection. Additional Aca23 and matched
controls were studied at ages of 10 and 18 months.
Results: Aca23 mice had no significant difference from WT in IOP level, and in both strains IOP rose with age. In
multivariable models, axial length and width were significantly larger in Aca23 than WT, became larger with age, and
were larger after exposure to glaucoma (n=227 mice). From inflation test data, the estimates of scleral stress resultants in
Aca23 mice were similar to age-matched and younger WT C57BL/6 (B6) mice, while the strain estimates for Aca23 were
significantly less than those for either WT group in the mid-sclera and in some of the more anterior scleral measures
(p<0.001; n=29, 22, 20 eyes in Aca23, older WT, younger WT, respectively). With chronic IOP elevation, Aca23 eyes
increased 9% in length and 7% in width, compared to untreated fellow eyes (p<0.05, <0.01). With similar elevated IOP
exposure, WT eyes enlarged proportionately twice as much as Aca23, increasing in length by 18% and in nasal—temporal
width by 13% (both p<0.001, Mann–Whitney test). In 4 month old control optic nerves, mean RGC axon number was not
different in Aca23 and WT (46,905±7,592, 43,628±11,162, respectively; p=0.43, Mann–Whitney test, n=37 and 29). With
chronic glaucoma, Aca23 mice had a mean axon loss of only 0.57±17%, while WT mice lost 21±31% (median loss: 1%
versus 10%, n=37, 29, respectively; p=0.001; multivariable model adjusting for positive integral IOP exposure).
Conclusions: The Aca23 mutation in collagen 8α2 is the first gene defect found to alter susceptibility to experimental
glaucoma, reducing RGC loss possibly due to differences in mechanical behavior of the sclera. Detailed study of the
specific changes in scleral connective tissue composition and responses to chronic IOP elevation in this strain could
produce new therapeutic targets for RGC neuroprotection.
Glaucoma  is  the  second  leading  cause  of  blindness
worldwide [1], and the risk factors for open angle glaucoma
(OAG), its most prevalent form, include structural features of
the eye, such as greater axial length, thinner central cornea,
and larger optic disc diameter [2]. Some of these risk factors
are clearly related to the connective tissue structures in the
eye. There are 14 chromosomal loci and mutations of three
genes that have been identified among primary OAG patients:
namely,  myocilin  (MYOC),  optineurin  (OPTN),  and  WD
repeat domain 36 (WDR36) [3]. The pathogenetic pathway by
which these mutations act has not been specified in detail.
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Street,  Baltimore,  MD;  Phone:  (410)  955-2777;  FAX:  (410)
955-2542; email: hquigley@jhmi.edu
Both higher mean IOP [4] and greater IOP fluctuation [5]
increase OAG injury, related to IOP-generated stress at the
optic nerve head (ONH). IOP-related stress in the cornea and
sclera is transmitted to the ONH at its periphery [6], which is
thought to be directly involved in retinal ganglion cell (RGC)
death by apoptosis [7]. The linkage between activation of
detrimental processes by IOP-induced stress and RGC death
represents  an  important  area  for  development  of  new
treatments.
To utilize the power of mouse genetics in the elucidation
of  glaucoma  pathogenesis,  numerous  models  have  been
developed  with  either  experimental  IOP  elevation  [8-17],
spontaneous  IOP  elevation  [18-20],  or  spontaneous  RGC
death [21,22]. Mammalian eyes, including those of mice, that
are subjected to experimental increases in IOP have neuronal,
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1093glial, and associated tissue alterations that are phenotypically
similar to human glaucoma [23-25]. Furthermore, lowering of
IOP slows the progressive loss of RGCs in both animal and
human glaucoma [26,27]. While mouse eyes differ in details
of  ONH  anatomy  from  primates,  they  share  the  site  of
glaucoma injury and the selective death of RGC. Jakobs et al.
[28] demonstrated that astrocytes in the mouse ONH simulate
the structure of the collagenous lamina cribrosa in primate/
human eyes, potentially transferring scleral wall tension to
ONH axons and capillaries. The mouse sclera has collagens,
elastin, and a general molecular content that is similar to
human sclera [29], though its thickness and diameter are 10
times smaller than those of human eyes [30].
Collagen  8  is  a  short  chain  collagen  found  in  the
extracellular matrix of several tissues, including Descemet’s
membrane in the cornea [31-34], the sclera, and the optic
nerve [35-37]. Defects in collagen 8α2 are associated with an
early  onset  form  of  Fuchs  corneal  dystrophy  [38,39].
Duplication  of  the  corresponding  mutation  for  Fuchs
dystrophy  in  the  mouse  gene  replicates  abnormalities  in
corneal  endothelium  and  Descemet’s  membrane  seen  in
affected humans [40]. Targeted knockout of both collagen
8α1 and 8α2 in mice produces a thinner than normal cornea
and an increased anterior chamber depth [41]. An induced
mutation in collagen 8α2 leading to a G257D amino acid
exchange affecting a highly conserved glycine residue in the
collagenous domain produced thinner cornea and enlarged
anterior chambers in mice homozygous for the defect (the
Aca23  mouse)  [42].  Visual  acuity  was  normal  and  the
histology of the retina and optic nerve were normal.
We  hypothesized  that  mouse  eyes  with  scleral
abnormalities  leading  to  increased  axial  length  would  be
differentially susceptible to glaucoma damage. The Aca23
mouse has both longer and wider than normal eyes and served
as a test of this hypothesis. There is some evidence that both
thinner cornea and defects in collagen 8 may be associated
with human OAG. The Ocular Hypertension Treatment Study
pointed  to  an  association  between  thinner  central  cornea
thickness  (CCT)  and  the  incidence  of  OAG  [43].  An
association was found between missense mutations in the
collagen  8α2  gene  and  thinner  CCT  in  human  glaucoma
patients [44]. Genome wide association study of residents of
Singapore also found potential linkage between thinner CCT
and a variant in the collagen 8α2 gene [45]. We therefore
studied the Aca23 mouse eye in detail, with aging, and after
induction  of  chronic  IOP  elevation  with  polystyrene
microbead injection into the anterior chamber.
METHODS
Animals: All animals were treated in accordance with the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research, using protocols approved and monitored by
the Johns Hopkins University School of Medicine Animal
Care and Use Committee. B6 wild type (WT) mice were
obtained from Jackson Laboratories, Bar Harbor, ME. The
Aca23 mutant mice were rederived from heterozygotic Aca23
mice from the laboratory of Drs. Puk and Graw [42]. Aca23
semen fertilized WT B6 oocytes in vitro. Progeny that were
heterozygous for the Aca23 mutation were crossed to produce
mice homozygous for the mutation and age-matched WT litter
mate controls. Mice were genotyped with primers directed at
the mutation site using PTC-225 thermocycler (MJ Research,
Waltham,  MA).  Polymerase  chain  reaction  products  were
digested using the restriction enzyme Hpy188III and analyzed
by electrophoresis on a 2% agarose gel to confirm the presence
of  the  G257D  exchange  (Gly  to  Asp)  missense  mutation
(Aca23) in the collagen 8A2 gene. We studied 425 control or
fellow eyes and 67 glaucoma eyes from WT B6 mice and 209
control or fellow eyes and 37 glaucoma eyes from Aca23
mutants.
Bead injection glaucoma: For anterior chamber injections to
produce glaucoma, mice were anesthetized by intraperitoneal
injection of general anesthesia, 50 mg/kg of ketamine, 10 mg/
kg of xylazine, and 2 mg/kg of acepromazine. Additional
topical  anesthesia  was  provided,  when  using  general
anesthesia, by 0.5% proparacaine hydrochloride eye drops
(Akorn Inc., Buffalo Grove, IL). In the injection protocol (the
4 + 1 method) [11], we injected 2 µl of 6 µm diameter beads,
then 2 µl of 1 µm diameter beads (Polybead Microspheres®;
Polysciences,  Inc.,  Warrington,  PA),  followed  by  1  µl  of
viscoelastic  compound  (10  mg/ml  sodium  hyaluronate,
Healon;  Advanced  Medical  Optics  Inc.,  Santa  Ana,  CA)
through a glass cannula pulled to a tip diameter of 50 µm
connected  by  polyethylene  tubing  to  a  Hamilton  syringe
(Hamilton,  Inc.,  Reno,  NV).  We  estimate  the  final
concentration as 3×106 beads per µl for 6 µm beads, and
1.5×107 beads per µl for 1 µm beads.
IOP  measurements  for  bead  injected  animals  were
completed before injection, at 10 min after injection, 3 days,
1 week, and weekly to sacrifice at 6 weeks after injection. For
IOP measurements, mice were anesthetized by inhalation of
isoflurane  using  the  RC2-  Rodent  Circuit  Controller
(VetEquip,  Inc.,  Pleasanton,  CA)  [11].  The  instrument
supplied oxygen from an attached tank mixed with isoflurane,
delivering  2.5%  of  isoflurane  to  the  animal.  IOP
measurements  were  made  using  the  TonoLab  tonometer
(TioLat, Inc., Helsinki, Finland), recording the mean of 6
readings with optimal variability grade.
Sacrifice, axial length, and width measurements: Animals
with induced glaucoma did not undergo inflation testing. They
received intraperitoneal injection of general anesthesia before
sacrifice  by  exsanguination,  followed  by  intracardiac
perfusion  with  4%  paraformaldehyde  in  0.1  M  sodium
phosphate buffer (pH=7.2). Orientation of the eye was marked
by a cautery mark on the superior cornea and optic nerves were
removed 1.0 mm distal to the globe. The eyes were inflated to
15 mmHg with a needle connected to a fluid-filled reservoir.
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1094Length  and  widths  were  measured  with  a  digital  caliper
(Instant  Read  out  Digital  Caliper;  Electron  Microscopy
Sciences, Hatfield, PA). The length was measured from the
center of the cornea to a position just temporal to the optic
nerve  insertion  to  the  sclera.  Nasal—temporal  width  and
superior—inferior  width  were  measured  at  the  largest
dimension at the equator, midway between the cornea and
optic nerve.
For  inflation  tested  animals,  intraperitoneal  general
anesthesia and topical anesthesia were delivered and final IOP
measurements  performed.  Eyes  were  enucleated  and
orientation was maintained by a cautery mark. After eyes were
placed in 0.1 M sodium phosphate buffer (pH=7.2), the fat and
muscle were removed, and the nerve was cut 1.0 mm posterior
to the globe. Then, the nerve was fixed by immersion in 4%
paraformaldehyde  in  0.1M  sodium  phosphate  buffer
(pH=7.2).  Measurements  of  the  eye  were  taken  before
inflation  testing  using  the  digital  caliper,  as  above.  After
completion of inflation testing, eyes were fixed by immersion
in 4% paraformaldehyde in 0.1 M sodium phosphate buffer
(pH=7.2).
Inflation test methods and analysis: The inflation test method
has been previously described in detail [46]. In brief, the eye
was glued to a fixture at the limbus and inflated through
pressure-controlled  injection  of  a  saline  solution.  Digital
image correlation (DIC) was used to locate the scleral edge as
seen from a superior view, extending from the fixture to the
optic  nerve  both  nasally  and  temporally  (Figure  1).  The
coordinates for a series of locations along the sclera were
obtained  from  DIC  at  the  baseline  pressure  (undeformed
configuration) and after displacement produced by inflation
(deformed configuration). We assumed that the sclera can be
described as a revolved ellipsoid, where the axis of revolution
was defined as the line connecting the ONH center to the
holder,  the  meridional  direction  was  defined  anterior-
posteriorly along the scleral edge, and the circumferential
direction was defined parallel to the equator. The assumption
of axisymmetry was needed to calculate the strain and stress
resultant response from the 2D position and displacement of
the scleral edge. To calculate the stress resultants, we modeled
the deformed sclera as a thin shell capable of supporting
constant  membrane  stresses  through  the  thickness  of  the
scleral wall. These assumptions allowed us to estimate the
stress resultants away from the ONH and fixture from the
applied pressure and deformed radii of curvature using static
equilibrium. The strains, on the other hand, were calculated
directly from the DIC displacements.
Inflation testing used enucleated, unfixed whole mouse
eyes  glued  with  cyanoacrylate  to  a  fixture.  The  anterior
chamber was connected through a 30 gauge needle and tubing
to a programmable transducer-pump manifold and immersed
in  phosphate-buffered  saline  at  22  °C.  The  preparation
permitted analysis of the posterior 2/3 of the globe. A CCD
video camera attached to a dissecting microscope viewed the
eye from superiorly, recording sclera edge images, every 2 s,
which were processed by DIC [47] software to extract the 2D
displacement field of selected points along the scleral edge.
The error in the displacement measurement was calculated
previously as ±0.46 μm. This included contributions from the
uncertainty in the pixel-distance calibration, ±0.36 μm, and
the inherent error of the DIC correlation, ±0.1 μm [46]. To
characterize the nonlinear, time-dependent material behavior,
testing began at a reference pressure, P0, determined for each
eye as the minimum pressure at which the sclera was no longer
wrinkled,  typically  6–8  mmHg.  The  specimen  was  first
subjected to 2 load-unload cycles from P0 to 30 mmHg at a
rate of 0.25 mmHg/s. The pressure was returned to P0 and held
for 10 min after each unloading to ensure full recovery of the
displacements. A ramp hold test was then conducted, at a rate
of 0.25 mmHg/s from P0 to 30 mmHg. The specimen was held
at 30 mmHg for 30 min before the pressure was brought back
to P0 for a recovery period of 20 min. The present analysis was
applied to the loading portion of the first load-unload cycle.
We successfully performed inflation tests on 31 Aca23 eyes,
23 WT B6 control eyes age-matched to the Aca23 eyes (17
and 18 months old, respectively), and 21 eyes of 4 month old
B6 mice. There were unsuccessful inflation tests not included
here on an additional 7 Aca23 eyes, 8 WT B6 age-matched
control  eyes,  and  13  eyes  of  4  month  old  B6  mice.
Unsuccessful  inflation  tests  had  obvious  leakage  from
cannulation, eyes that detached from the fixture, or technical
failure to complete the protocol.
To  calculate  the  stress  resultant-strain  response,  2
different  coordinate  systems  were  used  -  (1)  a  Cartesian
coordinate system (e1, e2), where e2 was the axis of revolution
(Figure 1 and Figure 2) a curvilinear coordinate system, s,
following the scleral edge (Figure 2A,B). The strains in the
meridional direction (Figure 2A), parameterized by the angle
Φ, and in the circumferential direction, parameterized by the
angle  θ  (Figure  2B),  were  measured  from  the  DIC
displacement field using the assumptions of a thin shell of
revolution. To obtain an analytical description of the scleral
edge, ellipses were fitted to the coordinates of the reference
image taken at the baseline pressure and to the coordinates of
the deformed images taken at up to 7 subsequent pressure
steps. The coordinates of the deformed positions x(s) were
given by:
x(s) = X(s) + u(s), 1
where X(s) is the coordinates of the points in the Cartesian
coordinate system in the reference image, and u(s) is the
corresponding  displacement  vector  (Figure  2C).  The
experiments  measured  the  Cartesian  components  of  the
displacement  u1  and  u2.  To  determine  the  strains,  the
displacement  components  were  fitted  to  a  fourth  order
polynomial  as  a  function  of  a  parameter  representing  the
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1095counterclockwise  angle  from  the  major  axis  of  the  fitted
ellipse (submitted), using the Matlab function polyfit. The
analytical displacements were used to calculate the Green-
Lagrange strain component in the meridional direction as
follows:
EΦ(s) =
1
2 (
dx(s)
ds
.
dx(s)
ds
− 1)
=
dX
ds
.
du
ds
+
1
2
du
ds
.
du
ds
The meridional strain, EΦ, describes the elongation of the
sclera in the anterior-posterior direction.
Circumferential strains were calculated from the ratio of
the deformed diameter d to the undeformed diameter D as
indicated  in  (Figure  2C),  using  the  assumption  of
axisymmetry:
Eθ(s) =
1
2 (
d(s)
D(s) )
2
− 1
2
3
To calculate the stress resultants in the circumferential and
meridional directions, we assumed that away from the ONH
and  fixture,  the  shear  stress  and  strain  components  were
negligible compared to the normal components and that the
effects of stress gradients from bending were also negligible.
This allowed the sclera to be modeled as a thin shell with
constant membrane stresses through the thickness [48]. The
meridional and circumferential stress resultants of a thin shell
of  revolution  subjected  to  an  internal  pressure,  p,  can  be
determined from equilibrium as:
nΦ = p
r2
2
, nθ = pr2
2r1 − r2
2r1
where r2 is the radius of curvature of the deformed meridian
and  r1  is  the  transverse  radius  of  curvature,  analytically
calculated  from  the  deformed  positions  (submitted).  The
stress resultants and strains were calculated at up to 8 points
located in regions 2 and 3 (Figure 1) and then averaged to
provide a single stress resultant-strain curve for region 2–3; a
separate  stress  resultant-strain  curve  for  region  4  was
4
Figure 1. Schematic of sclera locations.
This figure shows the schematic of an
inflation  tested  left  eye,  where  Rk
indicates the labeling of regions. The
positions of points along the scleral edge
were  calculated  for  the  initial  image
(reference  configuration)  and  for  the
subsequent  images  (deformed
configurations) in the (e1, e2) Cartesian
coordinate  system.  The  axis  of
revolution  was  defined  as  the  axis
passing through the center of the optic
nerve head (ONH) parallel to the axis of
the ONH.
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1096calculated. We used the ratios Eθ /EΦ and nθ /nΦ, to describe
the mechanical anisotropy of the tissue.
Among eyes with successful inflations, we were able to
apply the analysis to 29 Aca23 eyes, 22 WT B6 control eyes
age-matched to the Aca23 eyes (17 and 18 months of age,
respectively), and 20 eyes of 4 month old B6 mice. The 4
remaining successful inflations could not be analyzed because
of poor polynomial fitting of the displacement data or because
of poor DIC correlations at the pressure steps of interest.
RGC axon loss measurement: To assess RGC damage, we
estimated  axon  loss  in  optic  nerve  cross-sections  by  a
quantitative,  sampling  technique  [49,50].  After  initial
aldehyde fixation, the optic nerve was removed and post-fixed
in 1% osmium tetroxide, dehydrated in alcohol and stained
with 1% uranyl acetate in 100% ethanol for 1 h. Nerves were
embedded  in  epoxy  resin  and  1  µm  cross-sections  were
digitally imaged to measure each optic nerve area. Then, five
40×40 μm, randomly selected 100× images were made (Cool
Snap  camera,  Metamorph  Image  Analysis  software;
Molecular Devices, Downington, PA), comprising 9% of the
overall  nerve  area.  Masked  observers  edited  non-axonal
elements from each image to estimate true axon density. The
average axon density/mm2 was multiplied by the individual
nerve area to estimate the axon number. Experimental eyes
were compared to the mean axon number in pooled, fellow
eye nerves to yield percent axon loss.
RGC body loss quantification: Retinal whole mounts from
Aca23 and WT were fixed with 4% paraformaldehyde, rinsed
in buffer, then incubated overnight in 1:500 anti-β-tubulin
(Covance, Inc., Princeton, NJ). An AlexaFluor 488 labeled
secondary antibody (Invitrogen, Carlsbad, CA) was used to
detect the primary antibody. Nuclei were stained with 4’,6-
diamidino-2-phenylindole  dihydrochloride  (DAPI;
Invitrogen) during the final phosphate buffered saline wash
before being coverslipped with DAKO Fluorescent Mounting
Medium  (DAKO,  Carpenteria,CA).  Samples  were  imaged
with a Zeiss LSM 510 Meta Confocal Microscope (Zeiss
MicroImaging,  Thornwood,  NY).  Four  40×  images  were
taken  in  the  superior  and  in  the  temporal  retina.  Manual
quantification of RGC identified as positive for β-tubulin, as
well as all RGC layer cells labeled with DAPI was performed
in  masked  fashion,  using  Metamorph  Image  Analysis
software (Molecular Devices).
The Aca23 mouse eye has been reported to have normal
retinal architecture [42]; however, we performed histology on
retinal  cross  sections  to  check  for  presence  and  normal
thickness of all retinal layers. We analyzed the histology of
the retinas of 4 eyes from 4 animals of each genotype: 4 WT
treated retinas, 4 WT untreated retinas, 4 Aca23 treated retinas
and 4 Aca23 untreated retinas. After perfusion of the animals
and enucleation of the globes, we post-fixed the 16 retinas in
4% paraformaldehyde for 24 h, then in 2% glutaraldehyde/2%
paraformaldehyde for 24 h. They were embedded in epoxy
resin, cut at 1 µm sections, stained with 1% Toluidine Blue,
and examined by light microscopy.
Statistical evaluation: The parameters that were measured and
compared  included  IOP  at  baseline  and  during  chronic
glaucoma, including IOP average level and IOP exposure over
time (positive integral=area under the IOP versus time curve
in the treated eye that exceeded the area under the IOP versus
time curve in the control eye), axial length and widths, RGC
body and axon counts, and parameters of inflation testing.
Mean values were compared using parametric statistical tests
for data that were normally distributed and median values with
Figure 2. Schematic for scleral analysis.
Schematics  for  the  scleral  analysis
indicate  the  meridional  and
circumferential  directions  with  angles
Φ and θ, respectively, and the radius of
curvature of the undeformed meridian
with R2. A: The superior view of the
sclera with curvilinear coordinates (Φ),
which is used to locate a point along the
scleral edge. B: The posterior view of
the sclera indicating the two principal
directions  used  for  strains  and  stress
calculations. C: The superior view of the
undeformed (solid line) and deformed
(dashed line) scleral edge, indicating the
undeformed  position,  X(s),  the
deformed  position,  x(s),  the
displacement  vector,  u(s),  and  the
diameters d and D of the deformed and
undeformed  cross-sections  at  s,
respectively.
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normality testing. Multivariable regression models were used
to adjust some comparisons for variables of interest including
age, glaucoma status, and strain. Non-parametric ANOVA
testing  was  used  to  compare  stress  resultant—strain  data
among the 3 groups of mice that underwent inflation testing.
RESULTS
Intraocular pressure (IOP): Aca23 homozygotes had mean
IOP=13.0±3.9 mmHg (n=122 mice from 4.0 to 20.6 months
of age). In a regression model, IOP was significantly higher
in  older  animals  (p=0.03,  r2=0.037,  [IOP]=11.86  +  0.12*
[Age,  months]).  Likewise,  WT  littermate  B6  animals  had
mean  IOP=13.0±3.6  mmHg,  which  rose  similarly  and
significantly with age (p=0.04, r2=0.043, n=100 mice from 4.0
to 21.4 months of age, regression equation: [IOP]=11.92 +
0.12*  [Age,  months]).  There  was  no  difference  in  IOP
between Aca23 and WT mice (regression model adjusting for
age, p [diagnosis]=0.9, p [age]=0.003, n=222). Baseline IOP
measurements for animals in the bead injection experiment
showed  no  significant  differences  between  genotypes  or
treatment  groups  (Table  1).  In  a  previous  report,  we
demonstrated that the TonoLab tonometer reads accurately
when compared to manometrically determined IOP, both in
normal mice and in mice with thin, enlarged corneas [51].
Eye Size: Puk et al. [42] demonstrated that 11 week old Aca23
mice have longer anterior chambers and longer eyes than WT
B6 mice. We compared Aca23 mice and WT B6 in terms of
axial length, and widths in both the nasal—temporal meridian
and the superior—inferior meridian. Some eyes were fixed by
perfusion and inflated to 15 mmHg by a needle placed in the
anterior  chamber  before  measurement.  Other  eyes  were
measured  unfixed.  Some  were  also  exposed  to  chronic
experimental  IOP  elevation  by  bead  injection.  In  a
multivariable model, axial length was significantly longer in
older animals, longer in Aca23 than WT, and longer after
exposure  to  glaucoma,  but  was  not  related  to  method  of
fixation (Table 2, r2=0.58, data from 227 mice). In a similar
model, nasal—temporal eye width was significantly larger in
older mice, in Aca23 mice, after glaucoma, and after inflation
testing and perfusion fixation (p values: <0.0001, 0.0003,
<0.0001, 0.02, and <0.0001, respectively, r2=0.42). Likewise,
superior—inferior width was also significantly longer by age,
in Aca23 mice, and after glaucoma (p values <0.0001, 0.04,
<0.0001, respectively; r2=0.39), but was not related to whether
inflation  testing  had  been  performed  nor  to  the  fixation
method employed (both 0.4).
The Aca23 mice at 4 months of age were 12.2% longer
and 7.3% wider than WT, and at an average of 17 months of
age they were 16.4% longer and 2.6% wider than the wild type
(Table  3;  Aca23—WT  length  and  width  differences
p<0.0001; t-test). From 4 months to 17 months of age, Aca23
eyes became 9.7% longer and 3.9% wider (nasal—temporal).
WT mice grew 5.7% longer and 8.6% wider during the same
age span. Both length and width remained significantly larger
in older Aca23 mice than WT mice (p<0.0001 and 0.002, t-
test).
Inflation test results: Three groups of mice were inflation
tested, 29 eyes of 21 Aca23 mice at a mean age of 17 months,
22 eyes of 17 WT B6 mice at a mean age of 18 months, and
20 eyes of 20 WT B6 mice at a mean age of 4 months. The
difference  in  age  between  the  two  older  groups  was  not
significant (p=0.2, Mann–Whitney test). In the analysis, use
of either one eye per mouse or both eyes when both were tested
did not alter the conclusions as presented.
TABLE 1. BASELINE IOP STATISTICS.
Strain Treatment Mean St Dev Median
Aca23 Treated 12.11 2.4 13
  Untreated 12.62 2.3 13
WT Treated 12.37 2.6 13
  Untreated 12.20 3.0 13
          No significant differences across genotypes or between fellow eyes in baseline IOP, all p≥0.3, t-test.
TABLE 2. REGRESSION MODEL FOR AXIAL LENGTH.
 Parameter Coefficient SEM p value
Age 0.021 0.002 <0.0001
Strain −0.211 0.014 <0.0001
Glaucoma 0.298 0.028 <0.0001
Inflation testing 0.111 0.044 0.01
Fixation 0.08 0.049 0.1
          Coefficient, standard error (SE), and probability (p) values from multivariate regression model.
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1099In the more posterior (R2–3) scleral region, strain rose
significantly in both circumferential and meridional directions
with  increasing  IOP  (both  p<0.0001,  ANOVA).  Aca23
animals had less strain than younger WT animals at all of the
pressure  steps  analyzed  from  10  to  30  mmHg  in  both
circumferential  and  meridional  directions  (p<0.001,
ANOVA; Figure 3A,B). Aca23 eyes also had significantly
less circumferential strain than older WT animals from 10 to
26  mmHg  (all  p<0.05;  Figure  3A)  and  significantly  less
meridional strain than older WT at 10 and 30 mmHg (p<0.05,
ANOVA; Figure 3B). In all 3 groups of animals at this region,
circumferential  strain  exceeded  meridional  strain
significantly at lower IOP, but the difference was reduced at
higher IOP (p<0.01, ANOVA).
In the R2–3 region, stress resultants rose significantly
with increasing IOP (p<0.0001, ANOVA), but there were no
significant differences among the 3 groups in stress resultant
values (Aca23 versus younger or older WT, or younger versus
older WT).
In  the  more  anterior  (R4)  scleral  region,  strain  rose
significantly  circumferentially  and  meridionally  with
increasing IOP (Kruskal–Wallis ANOVA p<0.0001; Figure
3C,D). Aca23 eyes had significantly lower strain than age-
matched, older WT circumferentially at 4 of the 7 analyzed
pressure steps (14 to 26 mmHg; p<0.01, ANOVA Bonferroni
corrected;  Figure  3C).  Aca23  eyes  also  had  lower  strain
circumferentially compared to younger WT eyes at 6 of 7
analyzed pressure steps (10–30 mmHg; p<0.001; Figure 3C).
There were no significant differences between Aca23 and
either older or younger WT in meridional strain (Figure 3D).
Circumferential and meridional strain did not differ from each
other significantly in their response to increasing IOP, nor was
this anisotropy comparison significantly different from unity
in  Aca23,  older  WT  and  younger  WT  animals  (ANOVA
p=0.9). Strain did not differ between younger and older WT
animals in either circumferential or meridional directions (all
p>0.05, ANOVA; Figure 3C,D).
In  R4,  stress  resultant  values  rose  significantly  with
increasing IOP both circumferentially and meridionally (all
p<0.0001, ANOVA), but did not differ significantly between
Aca23 and older WT, Aca23 and younger WT, nor between
younger and older WT.
Effects of glaucoma: Chronic glaucoma was induced and its
effects measured in 37 Aca23 and 30 WT mice beginning at
3.5 to 4.4 months of age, for a period of 6 weeks from injection
of beads to sacrifice. Aca23 control eyes were significantly
longer than they were wide (p<0.0001, Table 3), while there
was no significant length—width difference in WT control
eyes  (p>0.05,  Mann–Whitney  test).  The  Aca23  glaucoma
mice increased eye length 9% and width 7% compared to
untreated  fellow  eyes  (p<0.05,  <0.01),  whereas  WT  mice
grew proportionately twice as much, increasing length by 18%
and width (nasal—temporal) by 13% (both p<0.001, Mann–
Whitney  test).  After  6  weeks  of  glaucoma,  there  was  no
significant difference in length or in nasal—temporal width
between Aca23 and WT mice (both p>0.05).
IOP was increased in every bead-injected eye at one or
more time points in both Aca23 and WT groups. The mean
Figure  3.  Stress  resultant  –  strain  of
Aca23, age-matched WT, and younger
WT in two different regions and in two
different  directions.  Graph  of  stress
resultants and strains in Aca23 (black),
age-matched  WT  (blue)  and  younger
WT  (red)  eyes  from  inflation  testing.
Data were analyzed from region 2–3 in
the circumferential direction (A) and the
meridional direction (B). Likewise, data
were  analyzed  from  region  4  in  the
circumferential  direction  (C)  and  the
meridional direction (D). In region 2–3,
the Aca23 eyes had significantly lower
strain  than  age-matched  and  younger
WT  at  several  pressure  levels  in  the
circumferential  and  meridional
directions. In Region 4, the Aca23 eyes
showed significantly lower strain than
both WT groups in the circumferential,
but  not  the  meridional  direction.  For
statistical analysis, please see Results.
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1100IOP differences between injected and fellow eyes over the six
week experiment are shown in Figure 4, with no significant
differences except at 2 weeks where the Aca23 group had
higher mean IOP difference. The estimated cumulative IOP
exposure was not significantly different between Aca23 and
WT, with mean positive integral IOP of 109±127 mmHg—
days (Aca23) and 88±79 mmHg– days (WT) and median
positive integral IOP=59 and 64 mmHg—days, respectively
(p=0.99, Mann–Whitney test).
In 4 month old mice, the number of axons in untreated
eyes was 46,905±7,592 in Aca23 and 43,628±11,162 in WT
(p=0.43, Mann–Whitney test, n=37 and 29, respectively). In
8 older Aca23 mice, aged 16–18 months, axon number was
51,285±16,106 (p=0.33 comparing Aca23 4 month old to
Aca23 16–18 month old, Mann–Whitney test).
After  6  weeks  of  glaucoma,  the  Aca23  mice  lost
0.57±17% of axons, while WT lost 21±31% (median loss: 1%
(Aca23) versus 10% (WT), n=37, 29, respectively; Table 4).
The greater axon loss in WT mice was significant (p=0.005,
Mann–Whitney  test;  p=0.001,  multivariable  regression
adjusting for positive integral IOP exposure). Representative
images of optic nerve cross sections from both genotypes and
both treatment conditions are shown in Figure 5.
As  confirmation  of  the  axon  loss  measures  for  RGC
damage, we counted RGC bodies identified by anti-β-tubulin
antibodies in whole mounts of the retina in 4 retinas of WT
and  4  retinas  from  Aca23  mice,  half  with  experimental
glaucoma and half from fellow controls. A total of 2,625 cells
were enumerated in these retinas. The mean number of cells
identified in the RGC layer of control Aca23 retinas in the
selected areas was 256±53 and in control WT retinas it was
227±28 (p=0.3, t-test). The median decrease in RGC cell
bodies labeled by β-tubulin was 17% in Aca23 eyes and 50%
in WT retina (p<0.0001, t-test). The corresponding median
axon loss for the eyes whose retinas were analyzed was 17%
in  Aca23  and  41%  in  WT  nerves,  showing  excellent
agreement between the RGC cell body loss and axon loss
(Figure 6).
We  prepared  cross-sections  of  the  retina  to  confirm
normal histology of the retina in both Aca23 and WT eyes.
There was normal retinal architecture and normal thickness of
retinal layers in both groups in non-glaucoma eyes by phase
Figure 4. Graph of IOP elevation for 2
weeks  after  treatment  with  bead
injection.  Mean  intraocular  pressure
difference  (mm  Hg)  between  injected
eye and fellow eye at various times after
injection for Aca23 (blue) and wild type
(red) mice. Significantly higher mean
IOP  difference  at  14  days  in  Aca23
group compared to wild type (*p=0.005,
Mann–Whitney test); other time periods
had no significant mean IOP difference
between strains (all p>0.06). Area under
curve  (positive  integral  IOP)  for  two
groups not significantly different (see
Results Section).
TABLE 4. AXON COUNTS AFTER EXPERIMENTAL GLAUCOMA.
Strain Treatment Mean SD Mean % loss ±SD Median % loss
Aca23 Untreated 46905 7592    
  Injected 46638 7987 0.6±17% 1%
WT Untreated 43628 11162    
  Injected 37025 14650 21±31% 10%
          WT=wild type, SD=standard deviation.
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1101contrast microscopy (Figure 7). Glaucoma treated eyes had
only diminution of RGC layer and nerve fiber layer, but no
sign of mid-retinal thinning that would occur if there had been
major  vascular  compromise  and  inner  retinal  ischemic
atrophy.
DISCUSSION
Aca23  mice  lost  significantly  fewer  RGC  with  chronic
glaucoma than did their WT littermates, with median loss
about one-half that of WT. We plan further, detailed studies
to identify the reasons for this difference in susceptibility to
glaucoma damage. It seems likely that the difference is due to
alterations in the structure or behavior of the ocular connective
tissues in these mice. At baseline, Aca23 eyes were longer and
wider than WT. Our initial hypothesis was that, all things
equal,  axially  longer  eyes  would  show  greater  glaucoma
damage. This hypothesis was based on the fact that human
glaucoma is more prevalent and more rapidly progressive in
those with longer eyes and eyes with thinner corneas [2].
Theoretically, the scleral stress would be greater at a given
IOP  in  a  larger  eye  than  in  a  smaller  eye.  Clearly,  this
simplistic notion does not apply to the situation in the Aca23
eye. In fact, our inflation data showed that Aca23 eyes had
less strain at similar stress than control mice in the sclera.
Furthermore, while they increased both length and width with
chronic IOP elevation, the enlargement was proportionately
less than half that of the WT mice. These tendencies to resist
stress and to exhibit less fixed deformation may be interpreted
to indicate that a stiffer response to IOP was protective against
RGC loss.
We have recently completed similar experiments that
compare RGC loss in chronic glaucoma between albino CD1
and pigmented B6 mice. CD1 mice have consistently greater
damage at the same IOP exposure compared to B6. With
inflation  testing,  the  two  strains  also  show  significant
differences in scleral behavior at baseline and the inflation
behavior became stiffer in both strains after chronic glaucoma.
Prior to glaucoma, the most significant difference between
CD1  and  B6  eyes  was  anisotropy  of  inflation  response
between the meridional and circumferential directions. In both
strains,  the  peripapillary  sclera  thinned,  but  they  differed
dramatically in the response of the rest of the sclera. There
was uniform scleral thinning in CD1, but actual thickening of
sclera in B6 after 6 weeks of glaucoma. We plan to study the
Figure 5. Axon loss in optic nerve cross
section. Representative images of optic
nerve  cross  sections  stained  with
Toluidine Blue. A: The untreated nerve
from a WT animal shows no damage.
B:  Six  weeks  post  intracameral
microbead injection, the axons of RGCs
show significant loss of axons. C: An
untreated Aca23 nerve resembles that of
an untreated WT animal. However after
microbead  injection  (D),  the  treated
Aca23  nerve  does  not  show  similar
damage to the WT treated nerve (C).
(scale bar=30 µm).
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1102detailed response of the sclera in Aca23, CD1, and WT B6
eyes to determine the molecular changes that underlie these
differences  in  susceptibility.  Initial  proteomic  analyses
suggest active remodeling induced by chronic glaucoma in
pathways  linked  to  transforming  growth  factor  β
(unpublished).
Stiffening of the ONH and sclera has been reported in
animal  glaucoma  models  and  in  living  and  post-mortem
human glaucoma eyes. Zeimer et al. [52] reported that the
ONH was stiffer in human glaucoma eyes and that the effect
was worse with greater RGC damage. Coudrillier et al. [53]
compared 24 normal and 11 glaucoma pairs of post-mortem
human eyes by inflation testing, determining that glaucoma
sclera was thicker and had a stiffer meridional response and
slower circumferential creep rates in peripapillary sclera than
normal  eyes.  Testing  of  living  human  eyes  by  indirect
methods  also  suggests  that  glaucoma  eyes  have  stiffer
responses [54,55]. However, it has not yet been determined if
human glaucoma eyes have features interpretable as stiffer
before damage, or, if their apparently greater stiffness is a
Figure  6.  RGC  loss  in  retinal  whole
mount.  Representative  images  of  the
RGC  layer  of  retinal  wholemounts
stained  with  DAPI  (blue)  and  anti-β-
tubulin  (green).  A:  An  untreated  WT
control  retina  with  nuclei  of  all  cells
including RGC, amacrines and others
labeled blue with DAPI. The cytoplasm,
dendrites  and  axons  of  RGC  labeled
green for tubulin. B: Glaucoma retina
from WT animal with substantial loss of
RGC. C: An untreated Aca23 control
retina  is  similar  to  untreated  WT.  D:
Aca23 retina after glaucoma, showing
one of the retinas with modest loss of
RGC compared to untreated Aca23 (C)
or WT (B), but less than that of treated
WT (B). (scale bar=20 µm).
Figure 7. Retinal architecture of Aca23 and WT. Representative cross-section images of the retinas of Aca23 and WT mice before treatment.
The Aca23 retina (A) has no differences in retinal layer thicknesses from WT (B; stained with Toluidine Blue; scale bar=20 µm).
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1103result of the disease. Girard et al. [56] studied 9 monkey
glaucoma  eyes,  determining  that  stiffness  increased  with
moderate  glaucoma  damage,  though  the  response  was
variable. Roberts et al. [57] modeled ONH behavior in 3 early
glaucoma  monkey  eyes  using  connective  tissue  volume
fractions.  They  hypothesized  that  scleral  stiffening  in
glaucoma may shield the ONH somewhat by an increased load
carried in the sclera. The monkey and mouse experimental
glaucoma data suggest that greater stiffness is an effect of
glaucoma. Whether greater or lesser compliance of the sclera
at baseline alters glaucoma susceptibility is an important area
for  future  investigation.  We  must  keep  in  mind  that,  in
addition, the response of the sclera to chronically elevated IOP
may be as important, or more so, than the baseline state of the
tissues. It is feasible to treat the sclera to alter its mechanical
stiffness. This approach could represent a new direction for
glaucoma treatment, reducing the strain generated by IOP at
the ONH.
The  decreased  susceptibility  to  glaucoma  damage
conferred by the Aca23 mutation could be related to features
other  than  those  studied  as  yet.  In  development,  it  is
hypothesized  that  collagen  8α2  is  a  factor  in  capillary
development. Potentially, the mutation could lead to altered
nutritional support to RGC and their axons in the retina and
ONH  that  protects  these  neurons  from  damage.  The
expression of collagen 8α2 in astrocytes of the optic nerve has
been suggested [36,37]. This raises the possibility that the
beneficial effect of the mutation is mediated through glial
interactions with RGC. The example of the Marfan syndrome
points  to  the  need  to  think  creatively  when  mutations  in
structural genes are studied as susceptibility factors in disease.
Dietz and colleagues [58] determined that the mutation in
fibrillin that leads to protean changes in connective tissues in
this disorder does not act by altering the molecular structure
of fibrillin itself, but rather by changing a signal sequence for
transforming growth factor β. As a result, translational therapy
is now being tested to inhibit the overaction of this pathway.
Potentially,  the  effect  of  collagen  8α2  mutation  could  be
mediated  by  mechanisms  other  than  simple  alterations  in
molecular structure.
Clearly, the Aca23 mouse exhibits dramatic structural
changes  in  ocular  connective  tissues.  The  larger  eye  and
thinner cornea are not an apparent result of exposure to a
different IOP level, as these eyes are insignificantly different
from control in this parameter. Nor is the phenotype simply a
difference in the cornea alone, as the widths of the globe at
the equator are significantly different from controls. There are
no detectable differences in the number of RGC at baseline,
either judged by axon counts or retinal anatomy. This mouse
is only one of several strains that we have identified, including
those with genetic alterations in elastin and fibromodulin, that
lead  to  larger  than  normal  eyes.  It  will  be  interesting  to
compare  how  these  various  models  respond  to  chronic
experimental glaucoma.
We have confirmed past studies of age effects in mice
[11] regarding their various features, including IOP and eye
size. In both mutant and WT mice studied here, there was a
small rise in IOP with age. Savinova et al. [59] studied age
effects  on  IOP  in  a  variety  of  mice  using  a  different
measurement  technique,  detecting  either  no  change  or  a
decline in some species. The mouse eye continues to elongate
up  to  one  year  of  age,  and  is  relatively  stable  thereafter
(submitted). Interestingly, we have found that the thickness of
the sclera in the WT B6 strain increases to one year, but then
thins substantially in the second year of life. Features that are
age-related must be taken into account in animal glaucoma
models.
We recognize that several aspects of the present research
deserve further study. The inflation studies conducted here did
not take into account the local scleral thickness. We have
recently developed methods to measure this for incorporation
into  a  more  sophisticated,  constitutive  model  of  inflation
behavior.  There  may  be  differences  in  susceptibility  to
experimental glaucoma by age. Further studies of Aca23 mice
at different ages could be informative.
In summary, a mutation induced in the collagen 8α2 gene
produced a larger eye and altered biomechanical behavior on
inflation  testing.  These  mice  were  significantly  less
susceptible  to  loss  of  RGC  in  an  experimental  glaucoma
model. Study of the role of ocular connective tissues in this
and  other  genetically-altered  mouse  models  could  lead  to
insights into pathogenesis and new therapeutic directions.
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